Registrations are closing soon. Don't miss your chance to join senior industry leaders including:

Boehringer Ingelheim - 6th Rare & Genetic Kidney Disease DD Summit
Calliditas - 6th Rare & Genetic Kidney Disease DD Summit
Maze Therapeutics - 6th Rare & Genetic Kidney Disease DD Summit
Novartis - 6th Rare & Genetic Kidney Disease DD Summit
Takeda - 6th Rare & Genetic Kidney Disease DD Summit
Travere - 6th Rare & Genetic Kidney Disease DD Summit
Vera Therapeutics - 6th Rare & Genetic Kidney Disease DD Summit
Vertex - 6th Rare & Genetic Kidney Disease DD Summit

...and many more.

Download Your Copy of the Agenda

6th Rare & Genetic Kidney Disease DD Summit Brochure

Having trouble downloading the brochure? Let us know and we’ll email it to you instead.

3 Days of Insights from Leading Renal Innovators

Hear how organizations, including Travere Therapeutics, Calliditas Therapeutics, Novartis, Vertex Pharmaceuticals, and more, are refining strategies, prioritizing assets, and staying ahead in rare kidney disease development.

6+ Hours of Dedicated Networking Sessions

Through interactive roundtables, dedicated networking sessions, and engaging poster sessions, see how the summit can support you in building the industry partnerships required to progress your drug development pipeline.

5+ Key Disease Indications Covered

Explore comprehensive coverage of IgAN, FSGS, ADPKD, Alport syndrome, and C3G, with tailored insights into the unique developmental challenges in each.